Focus Investment Banking

SEPTEMBER 17, 2024

Targeting sectors with rigorous technical specifications, regulatory compliance standards, and exacting quality requirements, MSK serves customers primarily in the medical, aerospace & defense and telecommunications end markets.

Investment Banking 52

Investment Banking Acquisitions Investment Bank 52

Growth Business

NOVEMBER 23, 2023

The fund will not invest in hardware, medical devices or consumer social networks. FPE Capital is a growth equity investor in the UK lower middle-market. Can provide a mixture of equity and mezzanine debt to businesses mostly at the Series A stage. The Notion portfolio includes Dixa, GoCardless, Mews, Paddle, Unbabel and Yulife.

Investment 111

Investment Funds Capital Business 111

How2Exit

MAY 9, 2023

Concept 2: DSOs and MSOs Buy Practices One of the topics discussed on the How to Exit podcast is the purchase of dental and medical practices by Dental Service Organizations (DSOs) and Medical Service Organizations (MSOs). There is no requirement to set up an MSO or DSO for the licensed medical professional.

Business 130

Business Investment IT Economics 130

Focus Investment Banking

APRIL 1, 2024

Summary Private equity-backed Physician Practice Management (“PPM”) companies in the ENT & Allergy space continued a conservative growth trajectory during Q1 2024. Introduction Private equity groups began investing in the ear, nose, and throat and allergy space in 2018.

Private Equity 52

Private Equity Equities Negotiation Investment 52

Tyton Partners

FEBRUARY 3, 2025

As the Federal Reserve moves toward a more predictable and potentially lower rate trajectory, financing conditions are expected to improve, enabling both strategic buyers and private equity investors to pursue transactions with greater confidence.

Education 52

Education Sale Investors Medical 52

Focus Investment Banking

MARCH 28, 2024

Summary Private equity’s investments in ophthalmology are entering a new, more mature lifecycle phase. We also expect many platform recapitalizations once private equity groups and lenders become comfortable with the interest rate environment. Most ophthalmology PPM organizations are still with their founding private equity sponsor.

Private Equity 52

Private Equity Equities Valuation Acquisitions 52

Cooley M&A

JANUARY 23, 2024

Complex and novel transaction structures for the sector also were a prominent result of the market and regulatory environment, with reverse mergers remaining a fixture and stock-for-stock deals and take-private transactions led by private equity sponsors entering the scene.

M&A 52

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 52

Cooley M&A

JANUARY 25, 2023

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Growth Business

SEPTEMBER 13, 2023

Investment range: £50,000 – £3m Sectors: fintech, insurtech, regtech, digital health and medical technology, artificial intelligence and machine learning, consumer services, digital media, semiconductors and displays, cybersecurity, enterprise software, autonomous systems and human computer interfaces, novel materials and quantum technology.

Capital 52

Capital Business Funds Investment 52

How2Exit

JUNE 19, 2023

He had made some good friends and close colleagues in the field and had seen how they raised funds to buy a small portfolio of businesses. The brand also receives many medical referrals from podiatrists and other foot specialists. John Prothrow had a background in mergers and acquisitions and had worked on the buy side of transactions.

Mergers and Acquisitions 130

Mergers and Acquisitions Business IT Acquisitions 130

Focus Investment Banking

JULY 20, 2023

CORE, a private equity firm focused on manufacturing, industrial technology, and industrial services, previously acquired GEM, a provider of precision deep-drawn metal components and mechanical assemblies, in February 2023. PMP”), a provider of specialty stamping and machining services. FOCUS represented CORE in this transaction.

Investment Banking 52

Investment Banking Manufacturing Bank Banking 52

Cooley M&A

JANUARY 25, 2024

Out of the Nordic countries, companies such as Novo Nordisk capitalized on massive revenue boosts from weight-loss medications (Wegovy and Ozempic) with multibillion-dollar acquisitions. As a result, we expect PE activity to be particularly robust throughout the year, driving cross-border dealmaking in the process.

M&A 52

M&A Mergers and Acquisitions Investment Government 52

Cooley M&A

JANUARY 25, 2023

However, deal activity fizzled in the second half of 2022, as high inflation, aggressive anti-inflation monetary policies, geopolitical instability, assertive antitrust regulators and tightening financing markets depressed target valuations, reduced strategic acquirer confidence and sidelined private equity sponsor buyers. trillion. [2]

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Global Newswire by Notified: M&A

JANUARY 6, 2025

06, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. NASDAQ: NARI) for $80 per share in cash, representing a total fully diluted equity value of approximately $4.9

Medical 56

Medical Portfolio Shares Equities 56

Cooley M&A

JANUARY 20, 2022

approved prescription cannabidiol medicine to its portfolio. In November, Johnson & Johnson announced that it will split itself into two publicly traded companies , separating its pharmaceutical and medical devices businesses from its consumer products business. driven assets. 19 fueled revenue aside, cash is still king.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Focus Investment Banking

FEBRUARY 11, 2025

McKessons acquisition of PRISM Vision Group is an important milestone for private equitys investments in optometry practices. At the same time, there has always been uncertainty about the ultimate home for these assets, since private equity does not keep its investments forever.

Private Equity 52

Private Equity Healthcare Equities Medical 52

Mergers and Inquisitions

MARCH 5, 2025

Its more of an industry focus at the intersection of several other strategies , such as long/short equity , event-driven investing , and even merger arbitrage. While plenty of bankers and equity research professionals from healthcare teams enter biotech hedge funds, people with advanced degrees (M.D.,

Funds 64

Funds Healthcare Mergers and Acquisitions Valuation 64